Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Equity Average (2016 - 2025)

Historic Equity Average for Sanara MedTech (SMTI) over the last 13 years, with Q3 2025 value amounting to $20.8 million.

  • Sanara MedTech's Equity Average fell 4901.43% to $20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.8 million, marking a year-over-year decrease of 4901.43%. This contributed to the annual value of $42.0 million for FY2024, which is 268.39% down from last year.
  • Latest data reveals that Sanara MedTech reported Equity Average of $20.8 million as of Q3 2025, which was down 4901.43% from $36.0 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Equity Average ranged from a high of $44.3 million in Q4 2023 and a low of $20.8 million during Q3 2025
  • Moreover, its 5-year median value for Equity Average was $39.6 million (2024), whereas its average is $36.9 million.
  • Its Equity Average has fluctuated over the past 5 years, first soared by 51745.43% in 2021, then crashed by 4901.43% in 2025.
  • Quarter analysis of 5 years shows Sanara MedTech's Equity Average stood at $32.3 million in 2021, then skyrocketed by 35.07% to $43.6 million in 2022, then increased by 1.73% to $44.3 million in 2023, then dropped by 10.71% to $39.6 million in 2024, then plummeted by 47.53% to $20.8 million in 2025.
  • Its Equity Average was $20.8 million in Q3 2025, compared to $36.0 million in Q2 2025 and $38.0 million in Q1 2025.